Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 76.60 |
| Open | 76.78 |
| Bid | 77.00 x 1300 |
| Ask | 77.66 x 800 |
| Day's range | 76.20 - 77.66 |
| 52-week range | 72.87 - 89.74 |
| Volume | |
| Avg. volume | 5,738,222 |
| Market cap | 96.755B |
| Beta (5Y monthly) | 0.34 |
| PE ratio (TTM) | 16.63 |
| EPS (TTM) | 4.67 |
| Earnings date | 31 Jan 2024 - 05 Feb 2024 |
| Forward dividend & yield | 3.00 (3.86%) |
| Ex-dividend date | 14 Dec 2023 |
| 1y target est | 89.76 |
Simply Wall St.Is Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE Of 26% Impressive?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Business WireGilead’s Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
FOSTER CITY, Calif., November 30, 2023--Gilead Sciences, Inc. (Nasdaq: GILD) today announced it will present new data at San Antonio Breast Cancer Symposium (SABCS) 2023, supporting the use of Trodelvy® (sacituzumab govitecan-hziy) in certain metastatic triple-negative breast cancer (mTNBC) and pre-treated HR+/HER2- metastatic breast cancer (mBC) patients.
Motley Fool2 Biotech Stocks You Can Buy and Hold for the Next Decade
These stocks aren't popular on the market right now, but investors shouldn't let that scare them off.
© 2023 Yahoo. All rights reserved.